��������

Gwynneth Borges is a highly experienced Process Engineer currently working at Editas Medicine, where responsibilities include key contributions as a Subject Matter Expert for the EDIT-301 Program, focused on autologous cell therapy for Sickle Cell Disease and Beta-Thalassemia. With a progression from Associate Process Engineer to Senior Research Associate, Gwynneth has optimized manufacturing processes, authored critical documentation, and facilitated important training. Prior experience includes a co-op role at Paragon Bioservices, specializing in recombinant AAV6 gene therapy vector production, as well as contributions to scientific communication as a writer for Scientifist. Academic credentials include a Master's degree in Chemical and Biomolecular Engineering from Johns Hopkins and a Bachelor's degree in Chemical Engineering from the University of Mumbai.